{"prompt": "['Alliance A221502', 'surgery. The patients will not be asked to return the pedometer. The local institutional', 'coordinator (not the rehabilitation interventionist) will go over the use of the pedometer and the', 'exercise materials with the patient. The patients will be asked to keep a log of their pre-operative', 'steps and mail the log to the registering site. The pedometers will be provided to the site prior', 'to enrollment.', '8.0', 'ADVERSE Events', 'We do not anticipate any adverse events related to participation in this study. PR has no reported risks', 'based on 3000 patients with severe COPD in the National Emphysema treatment trial that underwent', 'exercise training in more intensity compared to the one planned in this study.23', '9.0', 'MEASURES', '9.1', 'Chronic Respiratory Questionnaire (CRQ):', 'A 20-question inventory assessing the areas of dyspnea, fatigue, emotion, and feelings of', 'mastery. The fatigue, emotion, and mastery subscales ask the patient to rate how often in the last', 'two weeks they have been afflicted with a particular feeling or experience on a scale of 1 to 7,', 'with higher ratings indicating less symptom impairment. The dyspnea subscale gives an', 'additional option of indicating that a particular activity has not been done. 24-27', 'The CRQ takes', 'approximately 10 minutes to complete.', '9.2', 'MRC: Medical Research Council Dyspnea Score (MRC):', 'A 5 statement questionnaire where the patient selects the answer that most closely describes the', 'level of physical activity that precipitates their shortness of breath. The highest selected', 'statement (more severe) is the score. The MRC Dyspnea Scale takes less than 5 minutes to', 'complete.', '9.3', 'Linear Analog Self-Assessment (LASA):', 'A 5 question inventory measuring well-being on a scale of 1 (as bad as it can be) to 10 (as good', 'as it can be). The LASA takes less than 5 minutes to complete.', '10.0 END OF INTERVENTION', '10.1 Duration of Treatment', 'Patients in the intervention group will be scheduled for 10 sessions of mindful rehabilitation.', 'Six sessions is the minimum requirement. Patients will be followed until 6 months following', 'surgery.', '10.2 Managing ineligible patients and registered patients who never receive protocol', 'intervention', 'Definition of ineligible patient: A study participant who is registered to the trial but does not', 'meet all of the eligibility criteria is deemed to be ineligible.', 'Follow-up for ineligible patients who continue with protocol treatment', 'Patients who are deemed ineligible after registering may continue protocol intervention,', 'provided the treating physician, study chair, and executive officer agree there are no safety', 'concerns if the patient continues protocol intervention. All scans, tests, and data submission are', 'to continue as if the patient were eligible. Notification of the local IRB may be necessary per', 'local IRB policies.', '19', 'NCI Version Date 7/28/2017', 'Update #3']['Alliance A221502', 'Follow-up for ineligible patients who discontinue protocol treatment', 'For patients who are deemed ineligible after registering to the trial, who start treatment, but then', 'discontinue study treatment, the same data submission requirements are to be followed as for', 'those patients who are eligible and who discontinue study treatment.', 'Follow-up for patients who are registered, but who never start study treatment', 'If surgery is cancelled after registration, the participant will be considered a screen failure.', 'For all study participants who are registered to the trial but who never receive study intervention', '(regardless of eligibility), baseline and off-treatment notice data submission is required. See the', 'Data Submission Schedule accompanying the All Forms Packet.', '11.0 STATISTICAL CONSIDERATIONS', '11.1', 'Study Overview', 'Prospectively, 194 patients will be randomized to either ten sessions of preoperative pulmonary', 'rehabilitation VS. standard care at a number of healthcare centers throughout the United States.', '11.2 Sample Size, Accrual Time, and Study Duration', '11.2.1 Sample Size', 'A total of 194 patients (97 in each group) will be accrued to this study. This sample size', 'includes a 10% adjustment to account for attrition and will provide at least 80% power for', 'testing each aim of the study. Based on estimates from the pilot study, this sample size will', 'provide 80% power to detect a 25% difference in complication rates, a 3-day difference in', 'chest tube days, 3 day difference in length of stay, and a half standard deviation difference', 'in QOL endpoints.', '11.2.2 Accrual Rate and Accrual Duration', 'This study will be open for 36 months. We expect to close the study to accrual at month 30', 'to allow time for statistical analysis and publication. About 7 patients a month need to be', 'recruited to meet the 30 month proposed time line.', '11.2.3 Primary Endpoint Completion Date for ClinicalTrials.gov Reporting', 'For purposes of ClinicalTrials.gov reporting, the Primary Endpoint Completion Date', '(PECD) for this study is the time the last patient registered has been followed for at least 6', 'months.', '11.3 Statistical Design and Analysis for the Primary Endpoint', '11.3.1 Primary Endpoint', 'End point that will address AIM 1: hospital length of stay. The coordinator at each site will', 'be responsible for sending complete de-identified hospital records from each patient to Dr.', \"Benzo's staff, where a nurse blinded to the study arm will abstract the main outcome (length\", 'of stay and postoperative complications). See Section 6.3.', \"The primary endpoint will be assessed at Dr. Benzo's office (Mayo Clinic) with the\", 'complete admission hospital records in order to extract the length of stay. The records will', 'be mailed from the sites to', 'in a pre-stamped envelope. See Section 6.3.', '11.3.2 Analysis Plan', '20', 'NCI Version Date 7/28/2017', 'Update #3']\n\n###\n\n", "completion": "END"}